Ajinomoto Bio-Pharma Services Successfully Develops Highly Functional Ancestral RNA Ligase Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce the development of a new enzyme for double strand oligonucleotide formation with high productivity.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Ajinomoto
Contact Ajinomoto, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack